AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

HK inno.N Corp. engages in the provision of healthcare services. It offers EPOKINE, LEUKOKINE, and CALMTOP. The company was founded in 1984 and is headquartered in Seoul, South Korea.

NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Exzell Pharma operates as a prescription pharmaceutical company. It offers Swiss Natural supplements, Myoflex, and Ozonol. The company was founded by Pardeep Nijhawan in 2014 and is headquartered in Markham, Canada.

Develops therapeutic and monitoring products to improve the outcome of organ transplantation

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

Jiangsu Linxi Yaomu Technology Co., Ltd., established on 2015-01-20, Business scope includes technical research and development of medicinal wood;Medicinal wood household products,R&D and sales of cosmetics;building engineering,Decoration project,Landscaping project,Design of Municipal Public Works,construction,maintain;Decorative materials(Does not contain paint and coatings),Rubber products,wooden product,bamboo product,building materials,household items,Sales of hardware products;one type,Production and sales of Class II medical devices;Chinese Medicine.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jilin Boda Weiye Pharmaceutical Co., Ltd., established on 2010-04-14, Business scope includes licensed projects:pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Synvista Therapeutics, Inc. is a biotechnology company, which engages in the development of diagnostic tests and pharmaceutical drugs for the treatment of diabetes. The company was founded in October 1986 and is headquartered in Parsippany, NJ.

Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets. Elcelyx is headquartered in San Diego, California.